5-APB

5-APB
Clinical data
Other names	5-(2-Aminopropyl)benzofuran; 1-Benzofuran-5-ylpropan-2-amine
Routes of; administration	Oral
Drug class	Serotonin–norepinephrine–dopamine releasing agent; Serotonin 5-HT2 receptor agonist; Entactogen; Stimulant; Psychedelic
ATC code	None;
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class F2 (Prohibited psychotropics); DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; UN: Unscheduled.;
Pharmacokinetic data
Duration of action	3–8 hours
Identifiers
	IUPAC name 1-(1-benzofuran-5-yl)propan-2-amine;
CAS Number	286834-81-9 ;
PubChem CID	9837232;
ChemSpider	8012953 ;
UNII	2M3825704H;
CompTox Dashboard (EPA)	DTXSID101010106 ;
Chemical and physical data
Formula	C11H13NO
Molar mass	175.231 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(N)CC1=CC(C=CO2)=C2C=C1;
	InChI InChI=1S/C11H13NO/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-5,7-8H,6,12H2,1H3 ; Key:VKUMKUZDZWHMQU-UHFFFAOYSA-N ;
	(what is this?) (verify)

5-APB, also known as 5-(2-aminopropyl)benzofuran, is an entactogen of the phenethylamine, amphetamine, and benzofuran families. 5-APB and related drugs have sometimes been informally called "Benzofury".

5-APB was first described in the scientific literature in 2000 and emerged as a novel designer drug in 2010.